Can a smartphone app fight chemobrain? new trial aims to find out

NCT ID NCT05864274

Recruiting now Symptom relief Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a mobile cognitive training app can reduce 'chemobrain'—memory and thinking problems caused by chemotherapy—in people with gynecologic cancers. Sixty-four participants will use the app on their own phones while undergoing chemotherapy and complete thinking tests. The goal is to see if this simple, at-home tool can help ease these common side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cognitive training application
What this could lead to: If it works, this could offer a simple, at-home way to reduce memory and thinking problems during chemotherapy.
What could go wrong: This is a small, early study with no placebo group, so results may not be conclusive. The app may not help everyone, and benefits could be minor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER-RELATED COGNITIVE DIFFICULTIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer chemotherapy-induced toxicity female reproductive organ cancer ovarian cancer primary peritoneal carcinoma uterine cancer vaginal cancer vulva cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

University of Alabama at Birmingham
RECRUITING

Birmingham, Alabama, 35233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.